Novo’s next-generation obesity drug shows 25% weight loss in women in late-stage analysis – CNBC By Weight Loss Haven Novo’s next-generation obesity drug shows 25% weight loss in women in late-stage analysis CNBC Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest